Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$66.89 -1.46 (-2.14%)
Closing price 04:00 PM Eastern
Extended Trading
$66.88 -0.01 (-0.01%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COO vs. WST, ALGN, MMSI, ICUI, XRAY, HAE, QDEL, STAA, NEOG, and OSUR

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Neogen (NEOG), and OraSure Technologies (OSUR). These companies are all part of the "health care supplies" industry.

Cooper Companies vs. Its Competitors

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

West Pharmaceutical Services presently has a consensus target price of $318.56, suggesting a potential upside of 25.04%. Cooper Companies has a consensus target price of $86.64, suggesting a potential upside of 29.52%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.92
Cooper Companies
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.92

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.96B6.19$492.70M$6.6838.14
Cooper Companies$4.05B3.29$392.30M$2.0332.95

In the previous week, Cooper Companies had 11 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 23 mentions for Cooper Companies and 12 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.17 beat Cooper Companies' score of 0.51 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
12 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

West Pharmaceutical Services has a net margin of 16.48% compared to Cooper Companies' net margin of 10.08%. West Pharmaceutical Services' return on equity of 18.43% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.48% 18.43% 13.67%
Cooper Companies 10.08%9.82%6.54%

West Pharmaceutical Services has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 16 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$13.30B$15.96B$5.65B$10.29B
Dividend YieldN/A1.61%5.68%4.62%
P/E Ratio32.9516.7175.8426.11
Price / Sales3.292.33517.46171.31
Price / Cash12.0812.9437.5661.52
Price / Book1.593.2112.876.30
Net Income$392.30M$472.94M$3.29B$271.03M
7 Day Performance-0.49%-1.93%-0.26%-0.15%
1 Month Performance-8.97%-7.37%3.84%6.41%
1 Year Performance-38.30%-5.96%68.35%28.81%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
4.3312 of 5 stars
$66.89
-2.1%
$86.64
+29.5%
-37.8%$13.30B$4.05B32.9516,000Buyback Announcement
WST
West Pharmaceutical Services
4.9891 of 5 stars
$255.13
-0.6%
$318.56
+24.9%
-16.2%$18.45B$2.89B38.1910,600Positive News
Analyst Downgrade
ALGN
Align Technology
4.9213 of 5 stars
$132.57
+2.4%
$215.00
+62.2%
-48.5%$9.38B$4.00B22.3620,945Positive News
MMSI
Merit Medical Systems
4.6963 of 5 stars
$84.10
+1.7%
$107.50
+27.8%
-16.6%$4.90B$1.36B42.697,400Positive News
Analyst Forecast
ICUI
ICU Medical
4.3286 of 5 stars
$133.02
+3.0%
$181.00
+36.1%
-28.8%$3.19B$2.38B-87.5115,000Positive News
XRAY
DENTSPLY SIRONA
4.9154 of 5 stars
$13.42
-0.1%
$18.64
+38.9%
-50.7%$2.68B$3.79B-2.8314,000Positive News
HAE
Haemonetics
4.9395 of 5 stars
$51.19
+2.5%
$78.78
+53.9%
-32.9%$2.41B$1.36B15.663,023News Coverage
Analyst Forecast
QDEL
QuidelOrtho
4.2495 of 5 stars
$29.74
+3.5%
$39.20
+31.8%
-41.2%$1.95B$2.78B-4.556,600News Coverage
STAA
STAAR Surgical
2.384 of 5 stars
$27.16
flat
$20.67
-23.9%
-17.1%$1.34B$313.90M-14.071,211
NEOG
Neogen
3.2686 of 5 stars
$5.67
+3.8%
$7.50
+32.3%
-68.0%$1.19B$894.66M-1.132,110
OSUR
OraSure Technologies
2.0411 of 5 stars
$3.30
+0.3%
$3.00
-9.1%
-24.9%$240.62M$185.83M-4.93840Positive News

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners